CHRISTIAN S SCHADE

CIK 1214496 · Chairman & CEO · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.82M

Companies

5

Total Filings

47

Lifetime Open-Market Net

-$2.43M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IART Director 90,034 $16.49 $1.48M -$2.54M 25 2026-05-11
Omega Therapeutics, Inc. (OMGA) Delisted Director $0.14 $0 4 2024-06-21
APRE Chairman & CEO 13,212 $0.64 $8.5K $114.1K 8 2022-08-01
NRG Exec VP & Chief Financial Ofc 34,916 $123.95 $4.33M $0 2 2011-03-30
MEDX SVP & CFO 0 $35.60 $0 $0 5 2009-08-31

Recent Filings · Page 5 of 5

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2009-03-17 MEDX Grant (A) $0 EDGAR
2009-03-06 MEDX Grant (A) $0 EDGAR
2008-12-09 IART Grant (A) +630 $0 EDGAR
2008-08-21 IART Grant (A) +616 $30.0K EDGAR
2008-03-04 MEDX Grant (A) $0 EDGAR
2007-09-05 MEDX Grant (A) +65,000 $0 EDGAR
2007-06-14 IART Grant (A) +557 $0 EDGAR
Showing 4147 of 47
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.